A Study of BN102 in Patients With Previously Treated CLL/SLL and B-cell NHL

Summary

This is a Multicenter Phase 1/2 Clinical Study to Evaluate the Safety and Efficacy of BN102 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and B-cell Non-Hodgkin's Lymphoma (NHL)

Timeline

Start

2022-07

Primary completion

2024-07-30

Completion

2024-07-30

Outcome

Outcome not reported

Stopped: “Due to company decision”

Drugs

Indications